Uvera S.A.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2018-12-12
Share capital
180,850.00 PLN
Activity description

Uvera is developing a natural UV protective ingredient that is safe for human health and environmentally friendly, targeting the full spectrum of UV sun radiation. The company focuses on using biotechnology to create alternatives to harmful chemical sunscreens that can damage coral reefs and human health.

Registered address
ul. Dr. Jana Muszyńskiego 2/3.18, 90-151 Łódź, Poland
Website
Email
Social media
Electronic delivery address
AE:PL-51823-75952-CBAJU-23

Financials

Revenue history (in k)

Financial insight

  • Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.

From the notes

Current income tax (CIT due)$0

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 77 days late). All were audited by a statutory auditor.

  • 2025filed
  • 202404/07/2025
  • 202327/06/2024
  • 202215/07/2023
  • 202130/09/2022
  • 202030/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 21%
City · Łódź2,977 / 8,057
Top 37%
Voivodeship · Łódzkie6,431 / 15,323
Top 42%
Country · Poland122,505 / 297,069
Top 41%

Results vs industry

Revenue
This companyUSD 504.08kMedianUSD 56.72kAverageUSD 2.72m
Net profit
This companyUSD -756.13kMedianUSD -1.27kAverageUSD -93.01k
Operating costs
This companyUSD 498.04kMedianUSD 66.48kAverageUSD 2.68m
Assets
This companyUSD 663.97kMedianUSD 134.71kAverageUSD 3.04m

Offer

  • Sun protection ingredient
  • UV filter
  • Cyanobacteria biomass

Websites

  • uvera.euSafe and eco-friendly UV skin protection
    Google Tag ManagerApache

Job offers

The company has its own careers page: uvera.eu.

Authorized Representatives

Adam Kiciak age 50 – Management Board Member
Magdalena Jander age 40 – President of the Management Board

Manner of representation

In the case of a multi-member management board, each member of the management board acting independently is authorized to make declarations of will on behalf of the company and represent the company.

Supervisory board

Adam Aleksandrowicz age 54 – Supervisory Board Member
Piotr Pietrzak age 47 – Supervisory Board Member
Piotr Trębicki age 50 – Supervisory Board Member

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2018-12-22.

  • mBank
    44 1140 1108 0000 4349 3400 1002
  • mBank
    76 1140 1108 0000 4349 3400 1008
  • mBank
    33 1140 1108 0000 4349 3400 1006

Debt

No entries in the National Debtors Register (KRZ).

Public aid

6 public aid cases recorded, with a total value of $349,180.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$23,352
De minimis aid (in accordance with Commission Regulation 2023/2831)
$14,689
De minimis aid (in accordance with Commission Regulation 2023/2831)
$12,658

European Funds

2 projects recorded: 1 from FE lists ($71,814) and 1 Commission grant (FTS) ($2,841,585).

ProjectEU co-financing
Safe and natural uv skin protection
$2.8M
Preparation of a Eurogrant application planned to be submitted by UVera S.A. under the EIC Accelerator call
$71,814

Competitors

Name
Scope Fluidics S.A.
Centrum Innowacji I Wdrożeń Bio-Inwest sp. z o.o.
Nanogroup S.A.
Bioceltix S.A.
Pharmena S.A.
VET Cell Tech sp. z o.o.
Vaxican sp. z o.o.
Protexture sp. z o.o.
Bioactive-Tech sp. z o.o.
Bactrem sp. z o.o.

Change history

DateEvent
2022-01-14Share capital increase
2020-09-29Share capital increase
2018-12-12Entered in the register

FAQ

Last updated: 2026-03-29